Effect of Helicobacter pylori Eradication on the Development of Refl ux Esophagitis and Gastroesophageal Refl ux Symptoms: A Nationwide Multi-Center Prospective Study

키워드

참고문헌 (47)

1. Rokkas T, "The association between CagA status and the development of esophagitis after the eradication of Helicobacter pylori", Am J Med, 110, pp.703~707 (2001)
2. Hamada H, "High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis", Aliment Pharmacol Ther, 14, pp.729~735 (2000)
3. Labenz J, "Curing Helicobacter pylori infection in patients with duodenalulcer may provoke reflux esophagitis", Gastroenterology, 112, pp.1442~1447 (1997)
4. Kawanishi M, "Development of reflux esophagitis following Helicobacter pylori eradication", J Gastroenterol, 40, pp.1024~1028 (2005)
5. Take S, "Helicobacter pylori eradication may induce de novo, but transient and mild, reflux esophagitis: prospective endoscopic evaluation", J Gastroenterol Hepatol, 24, pp.107~113 (2009)
6. Fallone CA, "Is Helicobacter pylori eradication associated with gastroesophageal reflux disease", Am J Gastroenterol, 95, pp.914~920 (2000)
7. Cremonini F, "Meta-analysis: the relationship between Helicobacter pylori infection and gastrooesophageal reflux disease", Aliment Pharmacol Ther, 18, pp.279~289 (2003)
8. Laine L, "Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies", Am J Gastroenterol, 97, pp.2992~2997 (2002)
9. Ott EA, "Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator-blinded, placebocontrolled trial", Aliment Pharmacol Ther, 21, pp.1231~1239 (2005)
10. Befrits R, "Curing Helicobacter pylori infection in patients with duodenal ulcer does not provoke gastroesophageal reflux disease", Helicobacter, 5, pp.202~205 (2000)
11. Moayyedi P, "Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease", Gastroenterology, 121, pp.1120~1126 (2001)
12. Schwizer W, "Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial", Lancet, 357, pp.1738~1742 (2001)
13. Malfertheiner P, "Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease: results from a randomized trial programme", Aliment Pharmacol Ther, 16, pp.1431~1442 (2002)
14. Miwa H, "Improvement of reflux symptoms 3 years after cure of Helicobacter pylori infection: a case-controlled study in the Japanese population", Helicobacter, 7, pp.219~224 (2002)
15. Peek RM, "Helicobacter pylori and Gastroesophageal Reflux Disease", Curr Treat Options Gastroenterol, 7, pp.59~70 (2004)
16. McColl KE, "Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease", Am J Gastroenterol, 95, pp.101~105 (2000)
17. Lee ES, "Comparison of risk factors and clinical responses to proton pump inhibitors in patients with erosive oesophagitis and non-erosive reflux disease", Aliment Pharmacol Ther, 30, pp.154~164 (2009)
18. Malfertheiner P, "Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report", Aliment Pharmacol Ther, 16, pp.167~180 (2002)
19. 서검석, "Seroprevalence of Helicobacter pylori in South Korea", HELICOBACTER, 12, pp.333~340, BLACKWELL PUBLISHING
20. Chung JI, "Seroprevalence of Helicobacter pylori in the health check-up population in 2007", Korean J Helicobacter Upper Gastrointest Res, 8, pp.71~75 (2008)
21. Kim N, "The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: a nationwide multicentre prospective study in Korea", Aliment Pharmacol Ther, 27, pp.173~185 (2008)
22. Park JJ, "The prevalence of and risk factors for Barrett’s esophagus in a Korean population: a nationwide multicenter prospective study", J Clin Gastroenterol, 43, pp.907~914 (2009)
23. Locke GR, "A new questionnaire for gastroesophageal reflux disease", Mayo Clin Proc, 69, pp.539~547 (1994)
24. Sharma P, "The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria", Gastroenterology, 131, pp.1392~1399 (2006)
25. Kang JM, "The role of serum pepsinogen and gastrin test for the detection of gastric cancer in korea", HELICOBACTER, 13, pp.146~156, BLACKWELL PUBLISHING
26. Kim HY, "Clinical meaning of pepsinogen test and Helicobacter pylori serology in the health check-up population in Korea", EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 21, pp.606~612, lippincott
27. Haruma K, "Review article: influence of Helicobacter pylori on gastro-oesophageal reflux disease in Japan", Aliment Pharmacol Ther, 20(Suppl 8), pp.40~44 (2004)
28. Ahmed N, "Helicobacter pylori and gastroduodenal pathology: new threats of the old friend", Ann Clin Microbiol Antimicrob, 4, pp.1~10 (2005)
29. Tanaka I, "Effect of Helicobacter pylori eradication on gastroesophageal function", J Gastroenterol Hepatol, 19, pp.251~257 (2004)
30. Carroll IM, "the pestilence of Helicobacter pylori: insights into geographical genomics and pathogen evolution", Infect Genet Evol, 4, pp.81~90 (2004)
31. Arents NL, "The importance of vacA, cagA, and iceA genotypes of Helicobacter pylori infection in peptic ulcer disease and gastroesophageal reflux disease", Am J Gastroenterol, 96, pp.2603~2608 (2001)
32. Queiroz DM, "IL1B and IL1RN polymorphic genes and Helicobacter pylori cagA strains decrease the risk of reflux esophagitis", Gastroenterology, 127, pp.73~79 (2004)
33. Yaghoobi M, "Is there an increased risk of GERD after Helicobacter pylori eradication?: a meta-analysis", Am J Gastroenterol, 105, pp.1007~1013 (2010)
34. Feldman M, "Comparison of gastric acid secretion rates and serum pepsinogen I and II concentrations in occidental and oriental duodenal ulcer patients", Gastroenterology, 95, pp.630~635 (1988)
35. Hongo M, "Epidemiology of reflux disease and CLE in East Asia", J Gastroenterol, 38(Suppl 15), pp.25~30 (2003)
36. Rosaida MS, "Opposing time trends in the prevalence of duodenal ulcer and reflux esophagitis in a multiracial Asian population", Gastroenterology, 126(Suppl 1), pp.A443~ (2004)
37. Yeom JS, "Reflux esophagitis and its relationship to hiatal hernia", J Korean Med Sci, 14, pp.253~256 (1999)
38. Lee SJ, "Prevalence of endoscopic reflux esophagitis among Koreans", J Gastroenterol Hepatol, 16, pp.373~376 (2001)
39. Okamoto K, "Clinical symptoms in endoscopic reflux esophagitis: evaluation in 8031 adult subjects", Dig Dis Sci, 48, pp.2237~2241 (2003)
40. Osawa H, "Changes in plasma ghrelin levels, gastric ghrelin production, and body weight after Helicobacter pylori cure", J Gastroenterol, 41, pp.954~961 (2006)
41. Wu MS, "A case-control study of association of Helicobacter pylori infection with morbid obesity in Taiwan", Arch Intern Med, 165, pp.1552~1555 (2005)
42. Furuta T, "Effect of Helicobacter pylori infection and its eradication on nutrition", Aliment Pharmacol Ther, 16, pp.799~806 (2002)
43. Blaser MJ, "Helicobacter pylori persistence: biology and disease", J Clin Invest, 113, pp.321~333 (2004)
44. Song HJ, "Endoscopic reflux esophagitis in patients with upper abdominal pain-predominant dyspepsia", J Gastroenterol Hepatol, 22, pp.2271~2221 (2007)
45. Cho YS, "Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si, Korea", Am J Gastroenterol, 100, pp.747~753 (2005)
46. 오정환, "역류성 식도염으로 진단된 건강 검진자의 임상상", Journal of Neurogastroenterology and Motility (JNM), 12(1), pp.12~18 (2006), 대한소화기 기능성질환∙운동학회
47. Chung SJ, "Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups", Gut, 57, pp.1360~1365 (2008)

관련 논문AI추천